ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 833,58
-0,37%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kosan Biosciences (MM) (KOSN)

  7. Kosan Biosciences (MM) (KOSN) Actualités

KOSN

Kosan Biosciences (MM) (KOSN)

Kosan Biosciences (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KOSN
DateHeureSourceTitreSymboleSociété
26/06/200823h39Business WireBristol-Myers Squibb Completes Acquisition of Kosan Biosciences IncorporatedNASDAQ:KOSNKosan Biosciences (MM)
26/06/200822h34Edgar (US Regulatory)Kosan Biosciences Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200822h20Edgar (US Regulatory)Kosan Biosciences Inc- (25-NSE)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200819h36Edgar (US Regulatory)Kosan Biosciences Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200816h08Edgar (US Regulatory)Kosan Biosciences Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:KOSNKosan Biosciences (MM)
03/06/200816h00PR Newswire (US)Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive BreasNASDAQ:KOSNKosan Biosciences (MM)
30/05/200815h33MarketwiredWall Street News Alert: Stocks on the Move for Friday: CPYE! May 30, 2008NASDAQ:KOSNKosan Biosciences (MM)
30/05/200813h15MarketwiredEquity Spotlight for Friday, May 30, 2008: MDII Additional Product Order!NASDAQ:KOSNKosan Biosciences (MM)
29/05/200822h36Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200822h23Edgar (US Regulatory)Kosan Biosciences Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200820h20Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Kosan Biosciences Inc.NASDAQ:KOSNKosan Biosciences (MM)
29/05/200819h30Edgar (US Regulatory)Kosan Biosciences Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200818h32Edgar (US Regulatory)Kosan Biosciences Inc - Current report filing (8-K)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200817h06MarketwiredBellwetherReport.com Analyst Report on KOSN, ACEL, SHLD and SSCCNASDAQ:KOSNKosan Biosciences (MM)
29/05/200814h22Business WireBristol-Myers Squibb to Acquire Kosan BiosciencesNASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h27Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
20/05/200812h00PR Newswire (US)Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical OfficerNASDAQ:KOSNKosan Biosciences (MM)
14/05/200812h00PR Newswire (US)Kosan Announces Data Presentations at ASCO 2008 Annual MeetingNASDAQ:KOSNKosan Biosciences (MM)
12/05/200822h52Edgar (US Regulatory)Kosan Biosciences Inc - Quarterly Report (10-Q)NASDAQ:KOSNKosan Biosciences (MM)
06/05/200822h00PR Newswire (US)Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable ConferenceNASDAQ:KOSNKosan Biosciences (MM)
01/05/200823h00PR Newswire (US)Kosan Announces First Quarter 2008 Financial ResultsNASDAQ:KOSNKosan Biosciences (MM)
25/04/200813h00PR Newswire (US)Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial ResultsNASDAQ:KOSNKosan Biosciences (MM)
24/04/200812h08Edgar (US Regulatory)Kosan Biosciences Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:KOSNKosan Biosciences (MM)
16/04/200823h09PR Newswire (US)Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACRNASDAQ:KOSNKosan Biosciences (MM)
16/04/200823h06PR Newswire (US)Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACRNASDAQ:KOSNKosan Biosciences (MM)
14/04/200813h00PR Newswire (US)Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung CancerNASDAQ:KOSNKosan Biosciences (MM)
28/03/200820h13Edgar (US Regulatory)Kosan Biosciences Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:KOSNKosan Biosciences (MM)
18/03/200823h45PR Newswire (US)Kosan Restructures Workforce to Focus Resources on Lead Clinical ProgramsNASDAQ:KOSNKosan Biosciences (MM)
18/03/200821h00PR Newswire (US)Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive OfficerNASDAQ:KOSNKosan Biosciences (MM)
17/03/200821h53Edgar (US Regulatory)Kosan Biosciences Inc - Annual Report (10-K)NASDAQ:KOSNKosan Biosciences (MM)
 Showing the most relevant articles for your search:NASDAQ:KOSN

Dernières Valeurs Consultées

BIT
S29102
Societe Generale Effekten
BIT
O8JPV1
Morgan Stanley BV
BOV
PMSP11B
Prefeitura Municipal Sao...
BIT
8AGCQ
Etf
TSXV
LGF
LSE
JSGI
Jpmorgan Japan Small Cap...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés